Historical capital raisings
Företrädesemission 2026 / Rights issue 2026
Specialister inom inhalationsmedicin siktar mot globala miljardmarknader
Iconovo is a fully integrated inhalation partner. We can take projects all the way from molecule to market, managing the entire journey from concept to finalized pharmaceutical product. But we are also open to the partner taking the lead in late-stage development and manufacturing of finished goods.
Our competitive edge lies in combining inhaler expertise with proficiency in dry powder formulation. We leverage five proprietary device platforms, optimizing them to match specific drug properties. Additionally, we manage the manufacturing of Clinical Trial Material (CTM) and handle full regulatory documentation. With all expertise in-house, we deliver an accelerated, cost-effective, and de-risked path to market.